Markowitz et al. reported that IL-18 played an inflammation-dependent tumor-suppressive effect mainly by promoting the differentiation, activity, and survival of tumor-infiltrating T cells in hepatocellular carcinoma [71]. Here, IL18 is linked to neoplasm.